Arrangementer

Kommende

Tid og sted: 22. nov. 2019 10:00, Seminarrom 4424, Kristine Bonnevies hus

Investigating the effects of the neonicotinoid pesticide clothianidin on bumblebee foraging using an automated monitoring system.

Tid og sted: 28. nov. 2019 09:00, Seminarrom 4424, Kristine Bonnevies hus

Spawning variation in Northeast Arctic Haddock in the years 2000-2017

Tid og sted: 4. des. 2019 10:15, Seminarrom 3203 Kristine Bonnevies hus

Applying CRISPR-Cas9 gene-editing technology to make three types of ESR-1 Mutant Cell line (Y537N, D538G, Y537N-D538G) using wild type hormone-sensitive MCF7 cell line and validation of cell lines created

Tidligere

Tid og sted: 15. nov. 2019 13:00, Seminarrom 3213, Kristine Bonnevies hus

Impacts of UV radiation on inducible defense traits of Daphnia pulex

Tid og sted: 7. nov. 2019 13:00, Seminarrom 2203, Kristine Bonnevies hus

Molecular heterogeneity in multifocal primary prostate cancer.

Tid og sted: 31. okt. 2019 10:00, Seminarrom 4512, Kristine Bonnevies hus

Seasonal Cycle of Protist Plankton in Outer Oslofjorden with Emphasis on Nanoplankton

Tid og sted: 29. okt. 2019 13:00, Seminarrom 4619, Kristine Bonnevies hus

Developing methods for in vitro toxicity testing with Atlantic cod tissues

Tid og sted: 29. okt. 2019 11:00, Seminarrom 4619, Kristine Bonnevies hus

Developing methods for the detection and characterisation of micro- and nanoplastic in haemolymph of marine filter-feeding mussels

Tid og sted: 29. okt. 2019 10:15, Seminarrom 4512, Kristine Bonnevies hus

Identification of novel DNA methylation biomarkers for kidney cancer

Tid og sted: 29. okt. 2019 09:00, Seminarrom 4619, Kristine Bonnevies hus

Marine benthic foraminifera and microplastics (Accumulation and effects following short- and long-term exposure)

Tid og sted: 24. okt. 2019 13:00, Seminarrom 4512, Kristine Bonnevies hus

The movement of five wrasse species (Labridae) on the Norwegian west coast.

Tid og sted: 22. okt. 2019 10:00, Seminarrom 4512, Kristine Bonnevies hus

Which abiotic and biotic factors influence reproductive output in alpine populations of Ranunculus acris L.?

Tid og sted: 16. okt. 2019 13:00, rom 4512

”Investigating trophic interactions among herbivorous species in a rapidly changing Arctic tundra using DNA metabarcoding”

Tid og sted: 4. okt. 2019 14:15, rom 4512

”The effects of natural selection between life stages in a population of Italian sparrows (Passer italiae)”

Tid og sted: 26. sep. 2019 13:00, rom 4512

”En undersøkelse av bentiske diatomeer i Sandspollen og Drøbaksundet igjennom et år”  

Tid og sted: 25. sep. 2019 11:00, rom 4512

”Effects of Microplastics from Feed in Atlantic Cod (Gadus morhua)”

Tid og sted: 25. sep. 2019 09:00, rom 4512

”Mechanisms of Toxicity of Engineered Carbon Nanotubes and Titanium Dioxide Nanomaterials”

Tid og sted: 24. sep. 2019 12:30, Rom A2,2068 C/D Immi, Rikshospitalet

Mechanisms controlling the selection of anti-transglutaminase 2 B cell receptors in celiac disease

Tid og sted: 18. sep. 2019 14:00, Seminarrom 4424, Kristine Bonnevies hus

"A cross platform analysis of lncRNA expression associated with estrogen receptor status and methylation in breast cancer".

Tid og sted: 13. sep. 2019 09:00, rom 4512

”Effects of exposure to methylmercury and selenium in Atlantic cod (Gadus morhua)”  

Tid og sted: 12. sep. 2019 15:00, Seminarrom 2203, Kristine Bonnevies hus

Determining the clonal composition and antigen specificity of germinal center regulatory T cells

Tid og sted: 29. aug. 2019 12:00, Seminarrom 4512, Kristine Bonnevies hus

Can activation of the lactate receptor HCAR1 by lactate injections influence disease development in an animal model for Alzheimer’s disease?

Tid og sted: 23. aug. 2019 13:00, rom 3213

”Validation of DNA metabarcoding as a tool for diet analysis in reindeer (Rangifer tarandus tarandus L.)”

Tid og sted: 23. aug. 2019 10:15, rom 4512

”Functional and evolutionary investigations of the plant signaling peptide IDL1”

Tid og sted: 15. aug. 2019 14:00, Seminarrom 3203. Kristine Bonnevies hus

Exploring FLT3 driven acute myeloid leukemia for novel immunotherapeutic options.